{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T22:36:29Z","timestamp":1720564589873},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","medical-hypotheses.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.mehy.2016.05.001","type":"journal-article","created":{"date-parts":[[2016,5,4]],"date-time":"2016-05-04T17:54:00Z","timestamp":1462384440000},"page":"100-103","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Could ivabradine challenge be helpful for the diagnosis of intermittent sinoatrial node dysfunction in suspected patients?"],"prefix":"10.1016","volume":"92","author":[{"given":"Tolga Sinan","family":"G\u00fcven\u00e7","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rengin \u00c7etin","family":"G\u00fcven\u00e7","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yal\u00e7\u0131n","family":"Velibey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veysel Ozan","family":"Tan\u0131k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilaver","family":"\u00d6z","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Eren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2016.05.001_b0005","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1001\/jama.1968.03150030101028","article-title":"The sick sinus syndrome in atrial disease","volume":"206","author":"Ferrer","year":"1968","journal-title":"JAMA"},{"key":"10.1016\/j.mehy.2016.05.001_b0010","series-title":"Braunwald\u2019s textbook of cardiovascular diseases","first-page":"662","article-title":"Diagnosis of cardiac arrythmias","author":"Miller","year":"2015"},{"key":"10.1016\/j.mehy.2016.05.001_b0015","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/eurheartj\/eht150","volume":"34","author":"Brignole","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.mehy.2016.05.001_b0020","doi-asserted-by":"crossref","first-page":"e350","DOI":"10.1161\/CIRCUALTIONAHA.108.189742","volume":"117","author":"Epstein","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2016.05.001_b0025","doi-asserted-by":"crossref","first-page":"16","DOI":"10.7326\/0003-4819-124-1_Part_1-199601010-00003","article-title":"Cardiac event recorders yield more diagnoses and are more cost-effective than 48-hour Holter monitoring in patients with palpitations. A controlled clinical trial","volume":"124","author":"Kinlay","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mehy.2016.05.001_b0030","doi-asserted-by":"crossref","first-page":"848","DOI":"10.7326\/0003-4819-130-10-199905180-00020","article-title":"The evolving role of ambulatory arrhythmia monitoring in general clinical practice","volume":"130","author":"Zimetbaum","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mehy.2016.05.001_b0035","doi-asserted-by":"crossref","first-page":"24","DOI":"10.7326\/0003-4819-90-1-24","article-title":"Electrophysiologic evaluation of elderly patients with sinus bradycardia: a long-term follow-up study","volume":"90","author":"Gann","year":"1979","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mehy.2016.05.001_b0040","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.phrs.2006.03.006","article-title":"Funny channels in the control of cardiac rhythm and mode of action of selective blockers","volume":"53","author":"DiFrancesco","year":"2006","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.mehy.2016.05.001_b0045","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1054-3589(10)59003-3","article-title":"I(f) inhibition in cardiovascular diseases","volume":"59","author":"Thollon","year":"2010","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.mehy.2016.05.001_b0050","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1152\/physrev.00029.2008","article-title":"Hyperpolarization-activated cation channels: from genes to function","volume":"89","author":"Biel","year":"2009","journal-title":"Physiol Rev"},{"key":"10.1016\/j.mehy.2016.05.001_b0055","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev.physiol.65.092101.142734","article-title":"Hyperpolarization-activated cation currents: from molecules to physiological function","volume":"65","author":"Robinson","year":"2003","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.mehy.2016.05.001_b0060","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2016.05.001_b0065","series-title":"Braunwald\u2019s textbook of cardiovascular diseases","first-page":"748","article-title":"Specific arrhythmias: diagnosis and treatment","author":"Olgin","year":"2015"},{"key":"10.1016\/j.mehy.2016.05.001_b0070","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/cvr\/4.2.160","article-title":"The normal range and determinants of the intrinsic heart rate in man","volume":"4","author":"Jose","year":"1970","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.mehy.2016.05.001_b0075","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/europace\/eun211","article-title":"Consecutive administration of atropine and isoproterenol for the evaluation of asymptomatic sinus bradycardia","volume":"10","author":"Vavetsi","year":"2008","journal-title":"Europace"},{"key":"10.1016\/j.mehy.2016.05.001_b0080","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1054-3589(10)59003-3","article-title":"I(f) inhibition in cardiovascular diseases","volume":"59","author":"Thollon","year":"2010","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.mehy.2016.05.001_b0085","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s40265-013-0117-0","article-title":"Selective and specific inhibition of If with ivabradine for the treatment of coronary artery disease or heart failure","volume":"73","author":"Deedwania","year":"2013","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.mehy.2016.05.001_b0090","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.amjcard.2010.10.065","article-title":"Safety of ivabradine in patients with coronary artery disease and left ventricular systolic dysfunction (from the BEAUTIFUL Holter Substudy)","volume":"107","author":"Tendera","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.mehy.2016.05.001_b0095","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(08)61170-8","article-title":"Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Fox","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2016.05.001_b0100","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1136\/heartjnl-2014-305482","article-title":"Atrial fibrillation associated with ivabradine treatment: meta-analysis of randomised controlled trials","volume":"100","author":"Martin","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.mehy.2016.05.001_b0105","first-page":"3291","article-title":"Bradycardia and atrial fibrillation in patients with stable coronary artery disease treated with ivabradine: an analysis from the SIGNIFY study","volume":"36","author":"Fox","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.mehy.2016.05.001_b0110","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1093\/eurheartj\/ehp298","article-title":"Guidelines for the diagnosis and management of syncope (version 2009)","volume":"30","author":"Moya","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.mehy.2016.05.001_b0115","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1093\/eurheartj\/ehl164","article-title":"Lack of correlation between the responses to tilt testing and adenosine triphosphate test and the mechanism of spontaneous neurally mediated syncope","volume":"27","author":"Brignole","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.mehy.2016.05.001_b0120","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1161\/01.CIR.102.20.2509","article-title":"Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome: a prospective evaluation of 52 families","volume":"102","author":"Priori","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2016.05.001_b0125","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1161\/01.CIR.101.5.510","article-title":"Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts","volume":"101","author":"Brugada","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2016.05.001_b0130","series-title":"Braunwald\u2019s textbook of cardiovascular diseases","first-page":"685","article-title":"Diagnosis of cardiac arrythmias","author":"Miller","year":"2015"},{"key":"10.1016\/j.mehy.2016.05.001_b0135","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1124\/mol.105.020701","article-title":"Bradycardic and proarrhythmic properties of sinus node inhibitors","volume":"69","author":"Stieber","year":"2006","journal-title":"Mol Pharmacol"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987716300871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987716300871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T05:02:37Z","timestamp":1567832557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987716300871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":27,"alternative-id":["S0306987716300871"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2016.05.001","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Could ivabradine challenge be helpful for the diagnosis of intermittent sinoatrial node dysfunction in suspected patients?","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2016.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}